• By ICR Secretariat
  • Posted Thursday, September 16, 2021

AstraZeneca's COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome

https://www.fiercepharma.com/pharma/astrazeneca-s-covid-19-shot-joins-list-vaccines-flagged-for-rare-guillain-barre-syndrome

Two months after the FDA flagged Johnson & Johnson’s COVID-19 vaccine for the rare nerve disorder Guillain-Barre syndrome (GBS) Europe’s drug regulator has done the same for AstraZeneca’s COVID shot.